ANI Pharmaceuticals, Inc. Bottom Line Rises 63% In Q4

(RTTNews) - ANI Pharmaceuticals, Inc. (ANIP) announced earnings for its fourth quarter that climbed from last year.

The company said its bottom line totaled $9.82 million, or $0.84 per share. This was higher than $6.04 million, or $0.52 per share, in last year's fourth quarter.

Analysts had expected the company to earn $1.09 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter rose 111.8% to $38.21 million. This was up from $18.04 million last year.

ANI Pharmaceuticals, Inc. earnings at a glance:

-Earnings (Q4): $9.82 Mln. vs. $6.04 Mln. last year. -Earnings Growth (Y-o-Y): 62.6% -EPS (Q4): $0.84 vs. $0.52 last year. -EPS Growth (Y-o-Y): 61.5% -Analysts Estimate: $1.09 -Revenue (Q4): $38.21 Mln vs. $18.04 Mln last year. -Revenue Change (Y-o-Y): 111.8%

-Guidance: Full year EPS guidance: $3.58 - $3.94 Full year revenue guidance: $181 - $190 Mln